tiprankstipranks
Valneva Reports 2024 Financial Performance and Optimistic 2025 Outlook
PremiumCompany AnnouncementsValneva Reports 2024 Financial Performance and Optimistic 2025 Outlook
14d ago
Valneva jumps 19% after chikungunya vaccine wins UK approval
Premium
The Fly
Valneva jumps 19% after chikungunya vaccine wins UK approval
26d ago
MHRA grants Valneva marketing authorization for chikungunya vaccine
Premium
The Fly
MHRA grants Valneva marketing authorization for chikungunya vaccine
26d ago
Valneva reports Phase 2 results in children for its chikungunya vaccine
PremiumThe FlyValneva reports Phase 2 results in children for its chikungunya vaccine
1M ago
Valneva’s Chikungunya Vaccine Shows Promising Results in Adolescents
Premium
Company Announcements
Valneva’s Chikungunya Vaccine Shows Promising Results in Adolescents
1M ago
Valneva Engages Investors at J.P. Morgan Healthcare Conference
Premium
Company Announcements
Valneva Engages Investors at J.P. Morgan Healthcare Conference
2M ago
Valneva submits label extension application for chikungunya vaccine to FDA
PremiumThe FlyValneva submits label extension application for chikungunya vaccine to FDA
3M ago
Valneva Engages Investors with Promising Vaccine Developments
Premium
Company Announcements
Valneva Engages Investors with Promising Vaccine Developments
4M ago
Valneva SE Reports Profitable Nine-Month Performance
Premium
Company Announcements
Valneva SE Reports Profitable Nine-Month Performance
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100